MDS To Present At JPMorgan Healthcare Conference
03 Gennaio 2007 - 2:00PM
PR Newswire (US)
TORONTO, Jan. 3 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE:
MDZ), a leading provider of products and services to the global
life sciences markets, announced today that Stephen DeFalco,
President and Chief Executive Officer, will present at the JPMorgan
25th Annual Healthcare Conference in San Francisco on Monday,
January 8th, at 2:00 pm Pacific Standard Time / 5:00 pm Eastern
Standard Time. Interested parties may access the live webcast by
visiting the "Latest News" section of the MDS home page at
http://www.mdsinc.com/ and clicking on the conference link. An
audio archive and the presentation slides will also be available
after the event on the "Webcasts & Presentations" page in our
"For Investors" section of the MDS website. MDS Inc. is a global
life sciences company that provides market-leading products and
services that our customers need for the development of drugs and
the diagnosis and treatment of disease. We are a leading global
provider of pharmaceutical contract research, medical isotopes for
molecular imaging, radiotherapeutics, and analytical instruments.
MDS has more than 8,800 highly skilled people in 28 countries. Find
out more at http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24
hours a day. DATASOURCE: MDS Inc. CONTACT: Sharon Mathers,
Vice-President, Investor Relations and External Communications,
(416) 675-6777 ext. 34721,
Copyright